Analysts David Drug Forecasts Genetic Human Increase Prospects Sales Shires Speaks Therapies Upbeat
As analysts increase sales forecasts for Shire's new drug, CNBC speaks to David Pendergaft, President of Shire Human Genetic Therapies about the prospects for the drug.
CNBC | July 25, 2006
Tags:. .david. .forecasts. .speaks. .drug. .sales